» Articles » PMID: 32664866

Early Epidemiological Assessment of the Transmission Potential and Virulence of Coronavirus Disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2020 Jul 16
PMID 32664866
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since the first cluster of cases was identified in Wuhan City, China, in December 2019, coronavirus disease 2019 (COVID-19) rapidly spreads globally. Scientists have made strides in estimating key transmission and epidemiological parameters. In particular, accumulating evidence points to a substantial fraction of asymptomatic or subclinical infections, which influences our understanding of the transmission potential and severity of this emerging disease. In this study, we derive estimates of the transmissibility and virulence of COVID-19 in Wuhan City, China, by reconstructing the underlying transmission dynamics using multiple data sources.

Methods: We employ statistical methods and publicly available epidemiological datasets to jointly derive estimates of transmissibility and severity associated with the novel coronavirus. For this purpose, the daily series of laboratory-confirmed COVID-19 cases and deaths in Wuhan City together with epidemiological data of Japanese repatriated from Wuhan City on board government-chartered flights were integrated into our analysis.

Results: Our posterior estimates of basic reproduction number (R) in Wuhan City, China, in 2019-2020 reached values at 3.49 (95% CrI 3.39-3.62) with a mean serial interval of 6.0 days, and the enhanced public health intervention after January 23 in 2020 was associated with a significantly reduced R at 0.84 (95% CrI 0.81-0.88), with the total number of infections (i.e., cumulative infections) estimated at 1,906,634 (95% CrI 1,373,500-2,651,124) in Wuhan City, elevating the overall proportion of infected individuals to 19.1% (95% CrI 13.5-26.6%). We also estimated the most recent crude infection fatality ratio (IFR) and time-delay adjusted IFR at 0.04% (95% CrI 0.03-0.06%) and 0.12% (95% CrI 0.08-0.17%), respectively, estimates that are substantially smaller than the crude CFR estimated at 4.06%.

Conclusions: We have estimated key epidemiological parameters of the transmissibility and virulence of COVID-19 in Wuhan, China, during January-February 2020 using an ecological modeling approach that is suitable to infer epidemiological parameters with quantified uncertainty from partial observations collected by surveillance systems. Our estimate of time-delay adjusted IFR falls in the range of the median IFR estimates based on multiple serological studies conducted in several areas of the world.

Citing Articles

Estimation of standardized real-time fatality rate for ongoing epidemics.

Qu Y, Lee C PLoS One. 2024; 19(5):e0303861.

PMID: 38771824 PMC: 11108209. DOI: 10.1371/journal.pone.0303861.


Picture analysis of billboards and infographic graphics advertising COVID-19 on promoting preventive behaviors and taking vaccination against the Coronavirus disease pandemic.

Mohamadpour F, Askarian A, Askarian M Sci Rep. 2024; 14(1):6310.

PMID: 38491112 PMC: 10943230. DOI: 10.1038/s41598-024-56758-z.


Text analysis of billboards and infographic graphics advertising COVID-19 on promoting preventive behaviors and taking vaccination against the coronavirus pandemic and investigating the opinions of the Iranian adult population.

Mohamadpour F, Groot G, Askarian A, Askarian M BMC Public Health. 2024; 24(1):651.

PMID: 38429731 PMC: 10905937. DOI: 10.1186/s12889-024-18135-3.


Association of carbon monoxide poisonings and carboxyhemoglobin levels with COVID-19 and clinical severity.

Coskun A, Demirci B, Turkdogan K World J Methodol. 2023; 13(4):248-258.

PMID: 37771862 PMC: 10523238. DOI: 10.5662/wjm.v13.i4.248.


Insights from establishing a high throughput viral diagnostic laboratory for SARS-CoV-2 RT-PCR testing facility: challenges and experiences.

Pradhan S, Yashavarddhan M, Gupta A, Kumar P, Kumar A, Arif N Front Public Health. 2023; 11:1122715.

PMID: 37143990 PMC: 10152062. DOI: 10.3389/fpubh.2023.1122715.


References
1.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

2.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

3.
Ioannidis J . Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021; 99(1):19-33F. PMC: 7947934. DOI: 10.2471/BLT.20.265892. View

4.
Mizumoto K, Saitoh M, Chowell G, Miyamatsu Y, Nishiura H . Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. Int J Infect Dis. 2015; 39:7-9. PMC: 7110731. DOI: 10.1016/j.ijid.2015.08.005. View

5.
Shim E, Mizumoto K, Choi W, Chowell G . Estimating the Risk of COVID-19 Death During the Course of the Outbreak in Korea, February-May 2020. J Clin Med. 2020; 9(6). PMC: 7356403. DOI: 10.3390/jcm9061641. View